Moreover, recombinant TRAIL was demonstrated to inhibit autoimmune diseases in numerous animal models, such as those of rheumatoid arthritis, autoimmune encephalomyelitis, and autoimmune thyroiditis68,69. The gene discussed is TNFSF10; the disease is rheumatoid arthritis.